SAMN31383927
External Id
Regeneron Pharmaceuticals
INSDC center name
2022-11-23T00:50:19.897Z
INSDC first public
2022-11-23T00:50:19.897Z
INSDC last update
SRS15481004
INSDC secondary accession
live
INSDC status
Generic
NCBI submission model
Generic.1.0
NCBI submission package
SRS15481004
SRA accession
CD11b+ enriched
cell type
LLC tumor
disease state
Mus musculus
http://purl.obolibrary.org/obo/NCBITaxon_10090
organism
spleen
source_name
C57BL/6
strain
spleen
tissue
Tumor_Spleen
title
day 14
tumor stage